AIM ImmunoTech
@AimImmuno
We are an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders.
356 Following 3.5K Followers
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones
